|
|
|
|
LEADER |
03751nam a22004095i 4500 |
001 |
000281304 |
005 |
20211109101951.0 |
007 |
cr nn 008mamaa |
008 |
100301s2006 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387328249
|
024 |
7 |
|
|a 10.1007/0-387-32824-6
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Dipeptidyl Aminopeptidases :
|b Basic Science and Clinical Applications /
|c edited by Uwe Lendeckel, Dirk Reinhold, Ute Bank.
|
250 |
|
|
|a 1st ed. 2006.
|
260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
300 |
|
|
|a XXII, 226 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Structure and Function -- Peptide Substrates of Dipeptidyl Peptidases -- Phosphorus-Containing Inhibitors of Proteolytic Enzymes -- Biochemical Properties of Recombinant Prolyl Dipeptidases DPP-IV and DPP8 -- Prediction of Dipeptidyl Peptidase (DP) 8 Structure by Homology Modelling -- Dpiv-Related Enzymes -- Structure and Function in Dipeptidyl Peptidase IV and Related Proteins -- Expression and Function of Dipeptidyl Peptidase IV and Related Enzymes in Cancer -- DP8 and DP9 have Extra-Enzymatic Roles in Cell Adhesion, Migration and Apoptosis -- In Vivo Effects of a Potent, Selective Dppii Inhibitor -- Expression of Dipeptidyl Peptidase IV-Like Enzymes in Human Peripheral Blood Mononuclear Cells -- Dipeptidyl Peptidase 8 Has Post-Proline Dipeptidyl Aminopeptidase and Prolyl Endopeptidase Activities -- Prolyl Endopeptidase Cleaves the Apoptosis Rescue Peptide Humanin and Exhibits an Unknown Post-Cysteine Cleavage Specificity -- Distribution of Dipeptidyl Peptidase Iv-Like Activity Enzymes in Canine and Porcine Tissue Sections by RT-PCR -- Metabolic Disorders -- Relative Contribution of Incretins to the Glucose Lowering Effect of DP IV Inhibitors in Type 2 Diabetes Mellitus (T2DM) -- Dipeptidyl Peptidase IV: A Molecular Switch of Vascular Actions of Neuropeptide Y -- Immune Disorders -- Dipeptidylpeptidase IV (DPIV) and Alanyl-Aminopeptidases (AAPs) as a New Target Complex for Treatment of Autoimmune and Inflammatory Diseases—Proof of Concept in a Mouse Model of Colitis -- Dipeptidyl Peptidases and Inflammatory Bowel Disease -- Possible Role of DP IV Inhibitors in Acne Therapy -- Dipeptidyl Peptidase-IV Activity and/or Structure Homologs (DASH): Contributing Factors in the Pathogenesis of Rheumatic Diseases? -- Neuronal Diseases -- Dipeptidyl Peptidase IV (DP IV, CD26) and Aminopeptidase N (APN, CD13) as Regulators of T Cell Function and Targets of Immunotherapy in CNS Inflammation -- CD26/DP IV in T Cell Activation and Autoimmunity -- Cancer -- DPIV/CD26 and FAP in Cancer: A Tale of Contradictions -- Type-II Transmembrane Prolyl Dipeptidases and Matrix Metalloproteinases in Membrane Vesicles of Active Endothelial Cells -- Extra-Enzymatic Roles of DPIV and FAP in Cell Adhesion and Migration on Collagen and Fibronectin -- Role of Neuropeptide Y and Dipeptidyl Peptidase IV in Regulation of Ewing’s Sarcoma Growth -- The Role of CD26/DPP IV in Preservation of Early Pulmonary Graft Function.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Infectious diseases.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Metabolic diseases.
|
650 |
|
0 |
|a Medical biochemistry.
|
650 |
|
0 |
|a Diabetes.
|
650 |
1 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Infectious Diseases.
|
650 |
2 |
4 |
|a Neurosciences.
|
650 |
2 |
4 |
|a Metabolic Diseases.
|
650 |
2 |
4 |
|a Medical Biochemistry.
|
650 |
2 |
4 |
|a Diabetes.
|
700 |
1 |
|
|a Lendeckel, Uwe.
|e editor.
|
700 |
1 |
|
|a Reinhold, Dirk.
|e editor.
|
700 |
1 |
|
|a Bank, Ute.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|